QuantalX is a brand that specializes in brain health diagnosis and offers innovative solutions to detect and diagnose various brain disorders. Their flagship product, Delphi-MD, is a cutting-edge device that provides functional visualization and quantitative analysis for the early detection of brain abnormalities. With Delphi-MD, neurologists, point of care physicians, healthcare systems, and preventative care programs can access real-time, accurate clinical insights to make informed decisions about patient care.

This helps reduce the financial burden associated with brain health care while ensuring patients receive the best treatment possible. Delphi-MD is equipped with FDA Breakthrough designation for two clinical indications. It can detect early functional and structural brain abnormalities that indicate the early progression of stroke and dementia, as well as accurately diagnose conditions like Normal Pressure Hydrocephalus (NPH) and predict the effectiveness of a shunt implant treatment.

The device is scientifically validated, easy to use in any clinical setting, and provides highly accurate, real-time results. It also offers a clinical actionable report, making it a safe, non-invasive, and cost-effective solution for brain health diagnosis. Trust QuantalX and Delphi-MD for accessible and effective brain health care